Growth Metrics

Oculis Holding AG (OCS) Accumulated Expenses (2021 - 2025)

Quarterly Accumulated Expenses rose 20.26% to $25.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $25.0 million through Dec 2025, up 20.26% year-over-year, with the annual reading at $25.0 million for FY2025, 20.26% up from the prior year.

Oculis Holding AG's Accumulated Expenses history spans 5 years, with the latest figure at $25.0 million for Q4 2025.

  • Accumulated Expenses came in at $25.0 million for Q4 2025, up from $20.8 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $25.0 million in Q4 2025 to a low of $3.3 million in Q4 2021.
  • The 5-year median for Accumulated Expenses is $8.3 million (2022), against an average of $12.8 million.
  • Year-over-year, Accumulated Expenses dropped 19.36% in 2023 and then skyrocketed 209.8% in 2024.
  • Oculis Holding AG's Accumulated Expenses stood at $3.3 million in 2021, then skyrocketed by 151.81% to $8.3 million in 2022, then dropped by 19.36% to $6.7 million in 2023, then surged by 209.8% to $20.8 million in 2024, then increased by 20.26% to $25.0 million in 2025.
  • Per Business Quant, the three most recent readings for OCS's Accumulated Expenses are $25.0 million (Q4 2025), $20.8 million (Q4 2024), and $6.7 million (Q4 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn -
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn -
5 Akari Therapeutics 605.66 Bn 605.66 Bn -
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn
8 Evaxion A 65.12 Bn 65.10 Bn -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn
10 Oculis Holding AG 24.51 Bn 24.21 Bn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 24.98 Mn
Dec 31, 2024 20.77 Mn
Dec 31, 2023 6.71 Mn
Dec 31, 2022 8.32 Mn
Dec 31, 2021 3.30 Mn